Items Tagged ‘SLCO2B1’

May 13th, 2015

Statin Drugs Can Delay Prostate Cancer in Patients Receiving Androgen Deprivation Therapy, Study Shows


Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn’t take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows. In a study published online by JAMA Oncology, the researchers report that […]

View full entry

Tags: adt, androgen therapy, clinical trial, News, Prostate Cancer, SLCO2B1, statins